Tysabri Approved!

February 26 I wrote about a scheduled FDA review of Biogen Idec/Elan’s Tysabri for possible return to market. The U.S. Food and Drug Administration today has approved the return to market of Tysabri®. Hopefully, it will be available by July.

See more about the Tysabri approval at the National MS Society web site

technorati tags: Tysabri, FDA+approval, MS, multiple_sclerosis